Core Of Dale in Dale, IN

Core Of Dale is a medicare and medicaid certified nursing home in Dale, Indiana. It is located in Spencer county at 510 W Medcalf Road, Dale, Indiana 47523. You can reach out to the office of Core Of Dale via phone at (812) 937-7073. This skilled nursing facility has 60 federally certified beds with average occupancy rate of 58.83%. Its legal business name is Major Hospital and has the following ownership type - For Profit - Corporation.

Core Of Dale (Medicare CCN 155270) is certified by CMS (Centers for Medicare & Medicaid Services) and participates in both medicare and medicaid program. This means if you are part of medicare or medicaid program, you may consider this nursing facility for your medical needs. It was first certified by CMS in 1985 (39 years certified) and the last quality survey was conducted in January, 2020.

Name	Core Of Dale
Location	510 W Medcalf Road, Dale, Indiana
Certified By	Medicare and Medicaid
No. of Certified Beds	60
Occupancy Rate	58.83%
Medicare ID (CCN)	155270
Legal Business Name	Major Hospital
Ownership Type	For Profit - Corporation

Nursing Homes may have multiple NPI numbers. We have found possible NPI number/s associated with Core Of Dale from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number	1467509463
Organization Name	MAJOR HOSPITAL
Doing Business As	CORE OF DALE
Address	510 W Medcalf, Box 325, Dale, IN 47523
Phone Number	812-937-7073

News Archive

Smoking among youth declines, but much more needs to be done

The 2009 National Youth Tobacco Survey released today by the Centers for Disease Control and Prevention provides further evidence that the United States has made dramatic progress in reducing youth smoking, but the rate of decline has slowed significantly in recent years.

Anabolic steroids may cause severe kidney dysfunction

Athletes who use anabolic steroids may gain muscle mass and strength, but they can also destroy their kidney function, according to a paper being presented at the American Society of Nephrology's 42nd Annual Meeting and Scientific Exposition in San Diego, CA.

Æterna Zentaris receives commitments from institutional investors to purchase $15M in registered direct offering

Æterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrinology, announced today that it has received commitments from institutional investors to purchase US$15 million of securities in a registered direct offering.

OPTIMISTIC study aims to reduce avoidable hospitalizations, increase access to palliative care

The OPTIMISTIC study, an innovative initiative developed by research-clinicians from Indiana University and the Regenstrief Institute to improve health care, reduce avoidable hospitalizations and increase access to palliative care, is now underway in 19 nursing facilities throughout Central Indiana.

Read more Medical News

› Verified 8 days ago

Nursing homes vary in the quality of care and services they provide to their residents. The below quality ratings for Core Of Dale are calculated from three sources - health inspection results, staffing data, and quality measure data. This information gives you an indication of the care Core Of Dale give to their patients.

Ratings from Surveys (Inspections):
Ratings from Quality Measures:
Ratings from Staffing Data:
Overall Rating:

News Archive

Smoking among youth declines, but much more needs to be done

The 2009 National Youth Tobacco Survey released today by the Centers for Disease Control and Prevention provides further evidence that the United States has made dramatic progress in reducing youth smoking, but the rate of decline has slowed significantly in recent years.

Anabolic steroids may cause severe kidney dysfunction

Athletes who use anabolic steroids may gain muscle mass and strength, but they can also destroy their kidney function, according to a paper being presented at the American Society of Nephrology's 42nd Annual Meeting and Scientific Exposition in San Diego, CA.

Æterna Zentaris receives commitments from institutional investors to purchase $15M in registered direct offering

Æterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrinology, announced today that it has received commitments from institutional investors to purchase US$15 million of securities in a registered direct offering.

OPTIMISTIC study aims to reduce avoidable hospitalizations, increase access to palliative care

The OPTIMISTIC study, an innovative initiative developed by research-clinicians from Indiana University and the Regenstrief Institute to improve health care, reduce avoidable hospitalizations and increase access to palliative care, is now underway in 19 nursing facilities throughout Central Indiana.

Read more Medical News

› Verified 8 days ago

Number of Facility Reported Incidents	0
Number of Substantiated Complaints	0
Number of Fines	3
Total Amount of Fines in Dollars	$60778
Number of Payment Denials	1
Total Number of Penalties	4

The resident survey data of Core Of Dale is compared against the national average with the color code indicators: Better than National Average Worse than National Average

Experience Measure	Provider	National Avg.
Percentage of long-stay residents whose need for help with daily activities has increased	26.47	14.46
Percentage of long-stay residents who lose too much weight	3.76	5.51
Percentage of low risk long-stay residents who lose control of their bowels or bladder	41.25	48.41
Percentage of long-stay residents with a catheter inserted and left in their bladder	0.82	1.79
Percentage of long-stay residents with a urinary tract infection	8.33	2.65
Percentage of long-stay residents who have depressive symptoms	8.82	5.05
Percentage of long-stay residents who were physically restrained	0	0.23
Percentage of long-stay residents experiencing one or more falls with major injury	3.4	3.36
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine	72.79	93.87
Percentage of long-stay residents who received an antipsychotic medication	78.05	14.2